SMDC is a participating authority under Pharmaceutical Inspection Cooperation Scheme (PIC/S)
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
This collaboration turns kitting into a strategic advantage for sponsors and sites
Leuprolide Acetate injection is indicated in the palliative treatment of advanced prostatic cancer
Diroximel fumarate delayed-release capsules, 231 mg, are indicated for the treatment of relapsing forms of multiple sclerosis
Dexlansoprazole delayed-release capsules are a proton pump inhibitor
Sepsis is a life-threatening reaction to infection that overwhelms the body’s defenses
The trial will evaluate safety endpoints including dose-limiting toxicities and adverse events
Subscribe To Our Newsletter & Stay Updated